McCune C Anne, Al-Jader Layla N, May Alison, Hayes Sara L, Jackson Helen A, Worwood Mark
Department of Haematology, University of Wales College of Medicine, Cardiff, CF14 4XN, UK.
Hum Genet. 2002 Dec;111(6):538-43. doi: 10.1007/s00439-002-0824-1. Epub 2002 Sep 26.
In northern Europe, about 90% of patients with hereditary haemochromatosis (HH) are homozygous for a single mutation (C282Y) of the HFEgene and approximately 1 in 150 people in the general population carries this genotype. However, the clinical significance of HFE mutations remains uncertain, as is the proportion of people homozygous for C282Y who will develop clinical symptoms leading to a diagnosis of HH. A systematic review of patients with HH over a 2-year period within a defined UK region has revealed that only 1.2% of adult C282Y homozygotes have been diagnosed with iron overload and received treatment. In those in whom body iron load could be estimated, only 51% has more than 4 g iron (the diagnostic threshold for iron overload).
在北欧,约90%的遗传性血色素沉着症(HH)患者是HFE基因单一突变(C282Y)的纯合子,普通人群中约每150人中有1人携带这种基因型。然而,HFE突变的临床意义仍不确定,C282Y纯合子中会出现导致HH诊断的临床症状的人群比例也不确定。对英国特定地区两年内HH患者的一项系统评价显示,只有1.2%的成年C282Y纯合子被诊断为铁过载并接受了治疗。在那些可以估算体内铁负荷的人中,只有51%的人铁含量超过4克(铁过载的诊断阈值)。